Patent details

EP1971338 Title: COMBINATION OF ZD6474 AND PEMETREXED

Basic Information

Publication number:
EP1971338
PCT Application Number:
PCT/GB/2006/004750
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP068205665
PCT Publication Number:
WO/2007/071958
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF ZD6474 AND PEMETREXED
French Title of Invention:
COMBINAISON DE ZD6474 ET DE PEMETREXED
German Title of Invention:
KOMBINATION VON ZD6474 UND PEMETREXED
SPC Number:

Dates

Filing date:
19/12/2006
Grant date:
09/03/2011
EP Publication Date:
09/03/2011
PCT Publication Date:
28/06/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/09/2008
EP B1 Publication Date:
09/03/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/12/2013
Expiration date:
19/12/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/06/2011
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
VAN MALDEREN JOELLE
From:
28/04/2011
Address:
ROUTE D'ARLON 261, 8002, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WEDGE Stephen, Robert
Address:
United Kingdom (GB)

2

Name:
RYAN Anderson, Joseph
Address:
United Kingdom (GB)

Priority

1

Priority Number:
0526121
Priority Date:
22/12/2005
Priority Country:
United Kingdom (GB)

2

Priority Number:
0610706
Priority Date:
31/05/2006
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/517;
Filing date Document type Number of pages